Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0151733002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02461552 | APOTEX INC | APO-DEFERASIROX | Human | Yes | Prescription | 1 | DEFERASIROX | 250 MG |
Marketed | 02287439 | NOVARTIS PHARMACEUTICALS CANADA INC | EXJADE | Human | Yes | Prescription | 1 | DEFERASIROX | 250 MG |
Marketed | 02474336 | PHARMASCIENCE INC | PMS-DEFERASIROX | Human | Yes | Prescription | 1 | DEFERASIROX | 250 MG |
Marketed | 02464462 | SANDOZ CANADA INCORPORATED | SANDOZ DEFERASIROX | Human | Yes | Prescription | 1 | DEFERASIROX | 250 MG |
Marketed | 02463539 | TARO PHARMACEUTICALS INC | TARO-DEFERASIROX | Human | Yes | Prescription | 1 | DEFERASIROX | 250 MG |
Cancelled Post Market | 02407965 | TEVA CANADA LIMITED | TEVA-DEFERASIROX | Human | Yes | Prescription | 1 | DEFERASIROX | 250 MG |
Application information
Related information
Contact us
Version 4.0.3